Results
Difference in outcomes between patients treated with a short versus longer course of corticosteroids. *Other adverse effects included gastrointestinal bleeding, gastroesophageal reflux, sleep disturbance, symptoms of congestive heart failure or ischemic heart disease, fracture, and depression. systemic corticosteroids for short or longer duration in hospital settings. Study size varied from 21 to 314 patients, mean age was 65 to 73 years, and most patients were men (58% to 94% of included patients). Five studies used oral prednisolone only, and 3 used intravenous systemic corticosteroids. Length of therapy for shortduration groups included 3, 5, or 7 days, whereas longer-duration therapy lasted 10, 14, or 15 days. Studies were of good methodological quality, and most studies were at low risk of selection, performance, detection, and attrition bias, with some heterogeneity present in regard to inclusion criteria. Meta-analysis results suggest no difference in primary outcomes, including treatment failure, relapse, and drug adverse effects; or in secondary outcomes, including mortality, length of hospitalization, arterial blood gas components, lung function, and health-related quality of life (Table) .
Commentary
Chronic obstructive pulmonary disease is characterized by persistent, often progressive, airflow obstruction, as well as chronic pulmonary inflammation. 2 Chronic obstructive pulmonary disease exacerbations result in increased mortality and worsening quality of life. [2] [3] [4] [5] These exacerbations often require emergency department (ED) evaluation and management, with inciting causes typically including infection. 2, 6, 7 ED management includes addressing the underlying cause of exacerbation and decreasing airway obstruction and inflammation. 7, 8 Corticosteroids may reduce systemic inflammation and airway edema, and literature suggests that systemic corticosteroids decrease treatment failure, decrease length of stay, and improve lung function in chronic obstructive pulmonary disease. 2, 8, 9 However, these medications have adverse drug effects that may increase with longer duration, frequency of exposure, and total dose of corticosteroid. 2 The 2018 Global Initiative for Chronic Obstructive Lung Disease report recommends using corticosteroids for no longer than 5 to 7 days for acute chronic obstructive pulmonary disease exacerbation, 2 although other guidelines for corticosteroid therapy differ in regard to duration (7 to 14 days). 10, 11 This current metaanalysis compared short-term systemic corticosteroids (<7 days) with longer-term duration (>7 days) in patients with severe or very severe chronic obstructive pulmonary disease, finding no difference in likelihood of treatment failure, risk of relapse, or adverse medication effects between short-and longer-term therapies. Secondary outcomes, including mortality, length of hospitalization, lung function, arterial blood gas components, symptom scores, and quality of life, also did not differ. Included studies were at low risk for selection, detection, and attrition bias.
Limitations of this meta-analysis include the need to exclude 3 studies because of unavailable data and small number of included patients in the meta-analysis. This small number of patients also precluded subgroup analyses. The meta-analysis authors included 5 studies not published as full articles and excluded 3 studies because of inability to obtain full data. Evaluating studies published as an abstract only is a significant limitation because it can be challenging to critically appraise their methodologies for sources of bias and quality. These studies may have had significant methodological flaws, which may in turn have precluded publication. Another important meta-analysis limitation is that studies did not include patients with mild or moderate chronic obstructive pulmonary disease; however, these patients are more likely to be discharged from the ED and therefore highly relevant to emergency medicine practice. Next, this meta-analysis also excluded patients requiring assisted ventilation (invasive and noninvasive). Also, there was limited information through consensus or discussion with a third author. This meta-analysis suggests that short-term systemic corticosteroids are sufficient for chronic obstructive pulmonary disease exacerbation. Further study is necessary in regard to patients with mild or moderate chronic obstructive pulmonary disease, and this meta-analysis emphasizes the need for studies to provide full results in publication.
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